The risks and benefits of chemical fumigation in the health care environment

Journal of Occupational and Environmental Hygiene

Volumn 8, Issue 2, 2011, Pages 104-112

  Byrns, George ^a   Fuller, Thomas P ^a  

^a ILLINOIS STATE UNIVERSITY   (United States)

Author keywords

Chlorine dioxide; Decontamination; Fumigation; Health care; Hydrogen peroxide

Indexed keywords

CHLORINE DERIVATIVE; CHLORINE DIOXIDE; DISINFECTANT AGENT; FORMALDEHYDE; HYDROGEN PEROXIDE; OXIDE;

DISINFECTION; FUMIGATION; HOSPITAL; HUMAN; INFECTION CONTROL; METHODOLOGY; REVIEW; RISK FACTOR;

CHLORINE COMPOUNDS; DISINFECTANTS; DISINFECTION; FORMALDEHYDE; FUMIGATION; HOSPITALS; HUMANS; HYDROGEN PEROXIDE; INFECTION CONTROL; OXIDES; RISK FACTORS;

EID: 79955670851     PISSN: 15459624     EISSN: 15459632     Source Type: Journal    
DOI: 10.1080/15459624.2011.547453     Document Type: Article

References (66)

1. Klevens, R.M., J.R. Edwards, C.L. Richards Jr., et al.: Estimating health care associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 122(2):160–166 (2007).
2. Centers for Disease Control and Prevention (CDC): The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention (CS200891-A) by R.D. Scott. Atlanta, Ga: CDC, 2009.
3. Stone, P.W., S.A. Glied, P.D. McNair, et al.: CMS changes in reimbursement for HAIs: Setting a research agenda. Med. Care. 48(5):433–439 (2010).
4. Dancer, S.J., L.F. White, J. Lamb, et al.: Measuring the effect of enhanced cleaning in a UK hospital: A prospective cross-over study. BMC. Med. 7:28 (2009).
5. Bhalla, A., D.C. Aron, and C.J. Donskey: Staphylococcus aureus intestinal colonization is associated with increased frequency of S. aureus on skin of hospitalized patients. BMC. Infect. Dis. 7(105):1–7 (2007).
6. Oie, S., S. Suenaga, A. Sawa, et al.: Association between isolation sites of methicillin-resistant Staphylococcus aureus (MRSA) in patients with MRSA-positive body sites andMRSA contamination in their surrounding environmental surfaces. Jpn. J. Infect. Dis. 60(6):367–369 (2007).
7. Centers for Disease Control and Prevention (CDC): Management of Multidrug-Resistant Organisms in Healthcare Settings by J.D. Siegel, E. Rhinehart, M. Jackson, and L. Chiarello. Atlanta: CDC, 2006.
8. Zilberberg, M.D., G.S. Tillotson, and L.C. McDonald: Clostridium difficile infections among hospitalized children, United States, 1997–2006. Emerg. Infect. Dis. 16(4):604–609 (2010).
9. Wilcox, M.H., W.N. Fawley, N. Wigglesworth, et al.: Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J. Hosp. Infect. 54(2):109–114 (2003).
10. Denton, M., M.H. Wilcox, P. Parnell, et al.: Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J. Hosp. Infect. 56(2):106–110 (2004).
11. Baran, G.: Risk factors for nosocomial imipenem-resistantAcinetobacter baumannii infections. Int. J. Infect. Dis. 12(1):16–21 (2008)
12. Centers for Disease Control and Prevention (CDC): Guidelines for Environmental Infection Control in Health-Care Facilities: Recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Morb. Mortal. Wkly. Rep. 52 (RR-10). Atlanta, Ga: CDC, 2004.
13. Duckro, A.N., D.W. Blom, E.A. Lyle, et al.: Transfer of vancomycinresistant enterococci via health care worker hands. Arch. Intern. Med. 165(3):302–307 (2005).
14. De Lassence, A., N. Hidri, J.F. Timsit, et al.: Control and outcome of a large outbreak of colonization and infection with glycopeptideintermediate Staphylococcus aureus in an intensive care unit. Clin. Infect. Dis. 42(2):170–178 (2006).
15. Yokoe, D.S., L.A. Mermel, D.J. Anderson, et al.: A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect. Control Hosp. Epidemiol. 29(Suppl 1):S12–S (2008).
16. Boyce, J.M., G. Potter-Bynoe, C. Chenevert, et al.: Environmental contamination due to methicillin-resistant Staphylococcus aureus: Possible infection control implications. Infect. Control Hosp. Epidemiol. 18(9):622–627 (1997).
17. Catalano, M., L.S. Quelle, P.E. Jeric, et al.: Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J. Hosp. Infect. 42(1):27–35 (1999).
18. Wu, H.M., M. Fornek, K.J. Schwab, et al.: A norovirus outbreak at a long-term-care facility: The role of environmental surface contamination. Infect. Control Hosp. Epidemiol. 26(10):802–810 (2005).
19. Kuijper, E.J., B. Coignard, and P. Tull: Emergence of Clostridium difficile-associated disease inNorth America and Europe. Clin.Microbiol. Infect. 12(Suppl 6):2–18 (2006).
20. Huang, R., S. Mehta, D. Weed, et al.: Methicillin-resistant Staphylococcus aureus survival on hospital fomites. Infect. Control Hosp. Epidemiol. 27(11):1267–1269 (2006).
21. Sexton, T., P. Clarke, E. O’Neill, et al.: Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: Correlation with patient isolates and implications for hospital hygiene. J. Hosp. Infect. 62(2):187–194 (2006).
22. Boyce, J.M.: Environmental contamination makes an important contribution to hospital infection. J. Hosp. Infect. 65(Suppl 2):50–54 (2007).
23. Boyce, J.M., N.L. Havill, J.A. Otter, et al.: Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect. Control Hosp. Epidemiol. 29(8):723–729 (2008).
24. Weaver, L., H.T. Michels, and C.W. Keevil: Survival of Clostridium difficile on copper and steel: Futuristic options for hospital hygiene. J. Hosp. Infect. 68(2):145–151 (2008).
25. Drees, M., D.R. Snydman, C.H. Schmid, et al.: Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin. Infect. Dis. 46(5):678–685 (2008).
26. Barbut, F., D. Menuet, M. Verachten, et al.: Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect. Control Hosp. Epidemiol. 30(6):507–514 (2009).
27. Lu, P.L., L.K. Siu, T.C. Chen, et al.: Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii on computer interface surfaces of hospital wards and association with clinical isolates. BMC Infect. Dis. 9:164 (2009).
28. Wendt, C., B. Dietze, E. Dietz, et al.: Survival of Acinetobacter baumannii on dry surfaces. J. Clin. Microbiol. 35(6):1394–1397 (1997).
29. Wagenvoort, J.H., W. Sluijsmans, and R.J. Penders: Better environmental survival of outbreak vs. sporadic MRSA isolates. J. Hosp. Infect. 45(3):231–234 (2000).
30. French, G.L., J.A. Otter, K.P. Shannon, et al.: Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): A comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J. Hosp. Infect. 57(1):31–37 (2004).
31. Kramer, A., I. Schwebke, and G. Kampf: How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC. Infect. Dis. 6:130 (2006).
32. Wheeldon, L.J., T. Worthington, P.A. Lambert, et al.: Antimicrobial efficacy of copper surfaces against spores and vegetative cells of Clostridium difficile: The germination theory. J. Antimicrob. Chemother. 62(3):522–525 (2008).
33. Snyder, G.M., K.A. Thom, J.P. Furuno, et al.: Detection ofmethicillinresistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect. Control Hosp. Epidemiol. 29(7):583–589 (2008).
34. Jawad, A., H. Seifert, A.M. Snelling, et al.: Survival of Acinetobacter baumannii on dry surfaces: Comparison of outbreak and sporadic isolates. J. Clin. Microbiol. 36(7):1938–1941 (1998).
35. Akerlund, T., I. Persson, M. Unemo, et al.: Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J. Clin. Microbiol. 46(4):1530–1533 (2008).
36. Centers for Disease Control and Prevention (CDC): Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Morb. Mortal. Wkly. Rep. Vol. 51 (RR-16). Atlanta, Ga: CDC, 2002.
37. Edwards, J., G. Patel, and D.W. Wareham: Low concentrations of commercial alcohol hand rubs facilitate growth of and secretion of extracellular proteins by multidrug-resistant strains of Acinetobacter baumannii. J. Med. Microbiol. 56(Pt 12):1595–1599 (2007).
38. Association for Professionals in Infection Control and Epidemiology, Inc. (APIC): Guide to the Elimination of Clostridium difficile in Healthcare Settings. Washington, D.C.: APIC, 2008.
39. Streifel, A.J., P.P. Stevens, and F.S. Rhame: In-hospital source of airborne Penicillium species spores. J. Clin. Microbiol. 25(1):1–4 (1987).
40. Rice, N., A. Streifel, and D. Vesley: An evaluation of hospital specialventilation- room pressures. Infect. ControlHosp. Epidemiol. 22(1):19–23 (2001).
41. Rydock, J.P., and P.K. Eian: Containment testing of isolation rooms. J. Hosp. Infect. 57(3):228–232 (2004).
42. Smith, P.W., A.O. Anderson, G.W. Christopher, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: A consensus statement. Biosecur. Bioterror. 4(4):351–365 (2006).
43. Saravia, S.A., P.C. Raynor, and A.J. Streifel: A performance assessment of airborne infection isolation rooms. Am. J. Infect. Control 35(5):324–331 (2007).
44. Friedman, H., E. Volin, and D. Laumann: Terminal disinfection in hospitals with quaternary ammonium compounds by use of a spray-fog technique. Appl. Microbiol. 16(2):223–227 (1968).
45. Centers forDisease Control and Prevention (CDC): Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb. Mortal. Wkly. Rep. 50(42):909–919 (2001).
46. Andersen, B.M., M. Rasch, K. Hochlin, et al.: Decontamination of rooms, medical equipment and ambulances using an aerosol of hydrogen peroxide disinfectant. J. Hosp. Infect. 62(2):149–155 (2006).
47. Burton, N.C., A. Adhikari, Y. Iossifova, et al.: Effect of gaseous chlorine dioxide on indoor microbial contaminants. J. Air Waste Manag. Assoc. 58(5):647–656 (2008).
48. Berrington, A.W., and S.J. Pedler: Investigation of gaseous ozone for MRSA decontamination of hospital side-rooms. J. Hosp. Infect. 40(1):61–65 (1998).
49. Clark, J., S.P. Barrett, M. Rogers, et al.: Efficacy of super-oxidized water fogging in environmental decontamination. J. Hosp. Infect. 64(4):386–390 (2006).
50. Environmental Protection Agency (EPA): Compilation of Available Data on Building Decontamination Alternatives (EPA/600/R-05/036). Washington, D.C.: EPA, 2005.
51. ACGIH: TLVs and BEIs Based on the Documentation of the Threshold Limit Values for Chemical Substances and Biological Agents&Biological Exposure Indices. Cincinnati, Ohio: ACGIH, 2010.
52. Hardy, K.J., S. Gossain, N. Henderson, et al.: Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J. Hosp. Infect. 66(4):360–368 (2007).
53. Krause, J., G. McDonnell, and H. Riedesel: Biodecontamination of animal rooms and heat-sensitive equipment with vaporized hydrogen peroxide. Contemp. Top. Lab Anim Sci. 40(6):18–21 (2001).
54. Otter, J.A., M. Cummins, F. Ahmad, et al.: Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J. Hosp. Infect. 67(2):182–188 (2007).
55. Otter, J.A., and G.L. French: Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J. Clin. Microbiol. 47(1):205–207 (2009).
56. Hustinx, W.N., R.T. van de Laar, A.C. van Huffelen, et al.: Systemic effects of inhalational methyl bromide poisoning: A study of nine cases occupationally exposed due to inadvertent spread during fumigation. Br. J. Ind. Med. 50(2):155–159 (1993).
57. Langard, S., T. Rognum, O. Flotterod, et al.: Fatal accident resulting from methyl bromide poisoning after fumigation of a neighbouring house; leakage through sewage pipes. J. Appl. Toxicol. 16(5):445–448 (1996).
58. Environmental Protection Agency (EPA): Reregistration Eligibility Decision for Formaldehyde and Paraformaldehyde (EPA 739-R-08–004) Washington, D.C.: EPA, 2008.
59. Sebesteny, A., G. Milite, and P. Martelossi: Microbiologically monitored fumigation of a newly built SPF laboratory rodent facility. Lab Anim. 26(2):132–139 (1992).
60. Environmental ProtectionAgency (EPA): Fumigant Technologies Used to Inactivate Biological Agents on Indoor Materials. Washington, D.C.: EPA, 2009.
61. Wilson, S.C., C. Wu, L.A. Andriychuk, et al.: Effect of chlorine dioxide gas on fungi and mycotoxins associated with sick building syndrome. Appl. Environ Microbiol. 71(9):5399–5403 (2005).
62. American College of Occupational and Environmental Medicine (ACOEM): “Adverse Human Health Effects Associated with Molds in the Indoor Environment. ACOEM Evidence-based Statement.” Elk Grove Village, Ill.: ACOEM, 2002.
63. Eckstein, B.C., D.A. Adams, E.C. Eckstein, et al.: Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect. Dis. 7:61 (2007).
64. Carling, P.C., M.F. Parry, and S.M. Von Beheren: Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect. Control Hosp. Epidemiol. 29(1):1–7 (2008).
65. Goodman, E.R., R. Platt, R. Bass, et al.: Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect. Control Hosp. Epidemiol. 29(7):593–599 (2008).
66. Mayfield, J.L., T. Leet, J. Miller, et al.: Environmental control to reduce transmission of Clostridium difficile. Clin. Infect. Dis. 31(4):995–1000 (2000).